about
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepType I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaEffects of liver transplantation on endocrine function: a systematic review.HIV/HCV Co-infection, Liver Disease Progression, and Age-Related IGF-1 DeclineDevelopment and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study.Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.The dilution effect and the importance of selecting the right internal control genes for RT-qPCR: a paradigmatic approach in fetal sheep.IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic ratsPostoperative Insulin-Like Growth Factor 1 Levels Reflect the Graft's Function and Predict Survival after Liver TransplantationSerum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.Growth Hormone Mediates Its Protective Effect in Hepatic Apoptosis through Hnf6Consilience in sarcopenia of cirrhosis.Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis.Current status and future prospects of mesenchymal stem cell therapy for liver fibrosisInsulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment.Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United StatesRelationship between GH/IGF-1 axis, graft recovery, and early survival in patients undergoing liver transplantation.Isoflurane anesthesia induces liver injury by regulating the expression of insulin-like growth factor 1.Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives.Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.Regulation of IGFBP-2 expression during fasting.Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver CirrhosisDA Negatively Regulates IGF-I Actions Implicated in Cognitive Function via Interaction of PSD95 and nNOS in Minimal Hepatic Encephalopathy.Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1.Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in miceLeucine supplementation increases serum insulin-like growth factor 1 concentration and liver protein/RNA ratio in rats after a period of nutritional recovery.IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.Effects of administration of subtoxic doses of acetaminophen on liver and blood levels of insulin-like growth factor-1 in rats.Insulin-like growth factor 1 gene polymorphism in women with breast cancer.Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?Insulin-Like Growth Factor (IGF) System in Liver Diseases.
P2860
Q26771518-B57F71C8-CC80-465D-A6C1-22A2D15EACE9Q28080514-917CDA6D-18D1-4DDD-B7E6-AE2C1CBE4498Q30250357-03B3356C-1884-4420-8730-05A9ACE5460CQ33657640-E7DD86C0-9590-4650-81EE-35BB6821ABDBQ33859804-2D5C3B73-AAD2-46E8-9EC0-5A28CB519C32Q33957406-3F089BF6-6774-4D4E-A856-AE20AE9F1924Q35107341-98D46968-1EEC-44D4-B43C-467AF956631EQ35155563-1D090DFF-A420-499D-ADDE-8E91B8BC983EQ35685482-4B7366CB-B61F-4DD1-A6FE-B1B7B4DDDD10Q35694770-897D94CE-DEF9-4FD3-9862-09E673646906Q35995683-13FC166E-A04B-4F7D-80F2-C132BB6AE35DQ36217894-A3E1C5DF-C878-4EEC-823B-628C46CEBB8EQ36421047-35863F84-EC9F-4735-8025-6899302A72CBQ37014731-54838594-A6D2-48A0-9330-E9B55894B00EQ37430773-0B322FA2-F828-4A6E-A1DE-8F1DC09D7E0AQ37672148-8AC7EC35-022E-492B-B82E-2F2CD4B8ED07Q37695553-A486CDA9-F640-433F-ACAB-1421388C83A6Q37706109-01E9272B-D667-4632-80CD-73A6AFD1DC65Q37735041-46A74EF5-3421-4751-94DE-50BCA443912CQ38395222-446EB1C1-7A53-409E-9C2C-92E9D7666216Q38540380-9ED2D3C7-7A28-4958-B9F0-20BB74A85847Q38552383-97E3F897-F052-493F-BCDE-B4461B771F7DQ39810178-735EE409-52B1-4DFF-A901-CD654BE0EE6AQ41150264-64BC1753-42F6-4FC1-830D-1671FDD88D4EQ41400940-AEAA7AB0-D458-4943-93A9-7A340015CB7EQ41520593-E4C4E489-27C3-4263-928C-189F37CB0781Q41746582-A6F845B4-74B1-4DB0-B5D3-9ACFA8A052DEQ42094086-7D80AB67-F52F-4B11-B301-ED483237ECF9Q45187584-44557E10-654C-4EB2-8FAC-E26CDEB1A3E9Q47777518-F8238AE9-373C-4477-9959-C17F534B5D3BQ47878327-788213F8-BBDD-4BDD-B868-F13FC02BA974Q50791604-5450E807-21AB-4741-9006-55E5B0864426Q50878092-B6DEF24E-11E4-4621-9C64-BC15DBD9C51BQ52558393-70EFA4A0-8EA8-4812-945D-7D10FDF2D8F5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Insulin-like growth factor-I and the liver.
@en
Insulin-like growth factor-I and the liver.
@nl
type
label
Insulin-like growth factor-I and the liver.
@en
Insulin-like growth factor-I and the liver.
@nl
prefLabel
Insulin-like growth factor-I and the liver.
@en
Insulin-like growth factor-I and the liver.
@nl
P2860
P1433
P1476
Insulin-like growth factor-I and the liver
@en
P2093
Karen Bonefeld
P2860
P304
P356
10.1111/J.1478-3231.2010.02428.X
P50
P577
2011-01-24T00:00:00Z